NRXP NRX PHARMACEUTICALS INC Delisting Actions 8-K Filing 2023 - Delisting Notice NRX Pharmaceuticals received a notice from Nasdaq stating that the company's stock price has been below $1.00 per share for 30 consecutive business days, but it will continue to trade on Nasdaq. The company has 180 days to regain compliance with the minimum bid price requirement.Get access to all SEC 8-K filings of the NRX PHARMACEUTICALS INC